MMP9 and renal carcinoma: In addition to interfering with the activity of transcription factors, EF-24 was shown to resensitize renal cancer cells to TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis via reducing intracellular ROS production and MMP-2/MMP-9 activity [37].